Log in

NASDAQ:MRCCMonroe Capital Stock Price, Forecast & News

-0.20 (-2.42 %)
(As of 06/5/2020 04:00 PM ET)
Today's Range
Now: $8.07
50-Day Range
MA: $7.50
52-Week Range
Now: $8.07
Volume431,284 shs
Average Volume216,036 shs
Market Capitalization$164.99 million
P/E RatioN/A
Dividend Yield16.93%
Monroe Capital Corporation is a business development company specializing in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity investments, and buyouts in middle-market companies. The fund prefers to invest in casinos and gaming, broadcasting, publishing, alcoholic beverage and tobacco distribution, oil and gas, insurance, pharmaceuticals and bio sciences, aerospace and defense, commercial printing, natural rubber, glass, container and packaging, metals and mining, and real estate. It focuses to invest in the United States and Canada. The fund focuses on companies with a maximum of $25 million in EBITDA per year.
Read More
Monroe Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars

Industry, Sector and Symbol

Industry Investment advice
Current SymbolNASDAQ:MRCC



Sales & Book Value

Annual Sales$68.19 million
Cash Flow$1.40 per share
Book Value$12.20 per share


Net Income$19.21 million


Market Cap$164.99 million
Next Earnings Date8/4/2020 (Estimated)

Receive MRCC News and Ratings via Email

Sign-up to receive the latest news and ratings for MRCC and its competitors with MarketBeat's FREE daily newsletter.

Monroe Capital (NASDAQ:MRCC) Frequently Asked Questions

How has Monroe Capital's stock been impacted by COVID-19 (Coronavirus)?

Monroe Capital's stock was trading at $9.27 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MRCC shares have decreased by 12.9% and is now trading at $8.07. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Monroe Capital?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Monroe Capital in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Monroe Capital.

When is Monroe Capital's next earnings date?

Monroe Capital is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Monroe Capital.

How were Monroe Capital's earnings last quarter?

Monroe Capital Corp (NASDAQ:MRCC) released its earnings results on Friday, May, 8th. The financial services provider reported $0.33 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.35 by $0.02. The financial services provider had revenue of $15 million for the quarter, compared to the consensus estimate of $16.35 million. Monroe Capital had a positive return on equity of 11.94% and a negative net margin of 37.41%. View Monroe Capital's earnings history.

How often does Monroe Capital pay dividends? What is the dividend yield for Monroe Capital?

Monroe Capital declared a quarterly dividend on Monday, May 11th. Investors of record on Monday, June 15th will be given a dividend of $0.25 per share on Tuesday, June 30th. This represents a $1.00 dividend on an annualized basis and a yield of 12.39%. The ex-dividend date is Friday, June 12th. View Monroe Capital's dividend history.

What price target have analysts set for MRCC?

3 brokers have issued 12-month target prices for Monroe Capital's shares. Their forecasts range from $7.00 to $10.00. On average, they anticipate Monroe Capital's stock price to reach $8.50 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price. View analysts' price targets for Monroe Capital.

Has Monroe Capital been receiving favorable news coverage?

News stories about MRCC stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Monroe Capital earned a news impact score of -2.8 on InfoTrie's scale. They also assigned media stories about the financial services provider a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutMonroe Capital.

Are investors shorting Monroe Capital?

Monroe Capital saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 391,800 shares, an increase of 140.7% from the April 30th total of 162,800 shares. Based on an average daily volume of 238,100 shares, the short-interest ratio is currently 1.6 days. Approximately 2.0% of the shares of the stock are sold short. View Monroe Capital's Current Options Chain.

Who are some of Monroe Capital's key competitors?

What other stocks do shareholders of Monroe Capital own?

Who are Monroe Capital's key executives?

Monroe Capital's management team includes the following people:
  • Mr. Theodore L. Koenig, Chairman, Pres & CEO (Age 60)
  • Mr. Aaron D. Peck, Chief Investment Officer, CFO & Director (Age 48)
  • Mr. David H. Jacobson, Chief Compliance Officer (Age 58)

What is Monroe Capital's stock symbol?

Monroe Capital trades on the NASDAQ under the ticker symbol "MRCC."

Who are Monroe Capital's major shareholders?

Monroe Capital's stock is owned by a variety of institutional and retail investors. Top institutional investors include Blair William & Co. IL (4.36%), Cliffwater LLC (1.77%), Advisor Group Holdings Inc. (1.72%), Two Sigma Advisers LP (0.77%), Commonwealth Equity Services LLC (0.75%) and Virtus ETF Advisers LLC (0.75%). Company insiders that own Monroe Capital stock include Aaron Daniel Peck, Jeffrey A Golman, Jeffrey D Steele, Robert S Rubin and Theodore L Koenig. View institutional ownership trends for Monroe Capital.

Which major investors are selling Monroe Capital stock?

MRCC stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Two Sigma Investments LP, Mackenzie Financial Corp, Janney Montgomery Scott LLC, Virtus ETF Advisers LLC, Salzhauer Michael, Squarepoint Ops LLC, and Ashfield Capital Partners LLC. View insider buying and selling activity for Monroe Capital.

Which major investors are buying Monroe Capital stock?

MRCC stock was bought by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Cliffwater LLC, Blair William & Co. IL, Two Sigma Advisers LP, HighTower Advisors LLC, Commonwealth Equity Services LLC, LaFleur & Godfrey LLC, and Raymond James & Associates. Company insiders that have bought Monroe Capital stock in the last two years include Aaron Daniel Peck, Jeffrey A Golman, Jeffrey D Steele, Robert S Rubin, and Theodore L Koenig. View insider buying and selling activity for Monroe Capital.

How do I buy shares of Monroe Capital?

Shares of MRCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Monroe Capital's stock price today?

One share of MRCC stock can currently be purchased for approximately $8.07.

How big of a company is Monroe Capital?

Monroe Capital has a market capitalization of $164.99 million and generates $68.19 million in revenue each year. The financial services provider earns $19.21 million in net income (profit) each year or $1.42 on an earnings per share basis.

What is Monroe Capital's official website?

The official website for Monroe Capital is www.monroebdc.com.

How can I contact Monroe Capital?

Monroe Capital's mailing address is 311 SOUTH WACKER DRIVE SUITE 6400, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-258-8300 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.